WallStSmart

SEALSQ Corp (LAES)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 1318% more annual revenue ($258.90M vs $18.25M). ZEPP leads profitability with a -15.5% profit margin vs -187.3%. ZEPP earns a higher WallStSmart Score of 38/100 (F).

LAES

Avoid

30

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 5.0

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LAES.

ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LAES2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
118.2%10/10

Revenue surging 118.2% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

LAES4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$648.27M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-12.7%2/10

ROE of -12.7% — below average capital efficiency

Free Cash FlowQuality
$-25.70M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : LAES

The strongest argument for LAES centers on Price/Book, Revenue Growth. Revenue growth of 118.2% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : LAES

The primary concerns for LAES are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

LAES is growing revenue faster at 118.2% — sustainability is the question.

LAES generates stronger free cash flow (-26M), providing more financial flexibility.

Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (38/100 vs 30/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

SEALSQ Corp

TECHNOLOGY · SEMICONDUCTORS · USA

SEALSQ Corp (LAES) is a leading innovator in advanced cybersecurity solutions, leveraging blockchain technology and proprietary software to deliver comprehensive protection against evolving digital threats. The company focuses on secure identity management and access control, serving a wide range of industries and reinforcing operational integrity. With a strong emphasis on innovation and scalability, SEALSQ is well-positioned to capitalize on the growing demand for state-of-the-art security solutions, highlighting its potential for sustained growth and a competitive advantage in the fast-evolving cybersecurity landscape.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?